InvestorsHub Logo
Followers 8
Posts 387
Boards Moderated 0
Alias Born 03/19/2018

Re: None

Monday, 09/13/2021 5:58:43 PM

Monday, September 13, 2021 5:58:43 PM

Post# of 44695
We are honored by the opportunity to join with NRx on the EUA activation and compliance for ZYESAMI in treating some of the sickest patients suffering from COVID-19,” said Susan Kitlas, vice president, Precommercial Business Unit, IQVIA. “IQVIA’s experience and expertise within the COVID-19 market will be a valuable component in helping make this treatment more widely available.”